oblig
intracellular
parasit
fate
virus
intric
link
metabol
host
cell
virus
exploit
host
cell
mechan
throughout
life
cycl
entri
replic
assembl
egress
final
matur
step
cycl
potenti
point
antivir
intervent
virusinfect
cell
produc
interferon
ifn
trigger
transcript
upregul
ifnstimul
gene
isg
review
schneider
et
al
combin
action
hundr
express
isg
protein
creat
multipl
line
defens
viral
infect
surpris
differ
isg
block
differ
pathway
vari
potenc
differ
class
virus
schoggin
et
al
knowledg
isg
effector
function
somewhat
bias
toward
inhibit
earli
replic
stage
entri
viral
translat
initi
howev
viral
assembl
releas
proven
achil
heel
virus
target
therapeut
small
molecul
influenza
viru
iav
neuraminidas
inhibitor
proteas
inhibitor
intrins
isg
tetherin
neil
et
al
viperin
wang
et
al
studi
establish
screen
would
also
uncov
host
factor
inhibit
late
stage
viral
replic
cycl
use
iav
model
viru
appli
approach
accur
monitor
sever
round
viral
replic
presenc
singl
overexpress
isg
discov
direct
antivir
function
wellknown
gene
encod
ny
et
al
demonstr
inhibit
iav
matur
target
host
proteas
need
viral
glycoprotein
cleavag
physiolog
relev
natur
proteolyt
landscap
vitro
vivo
final
link
human
genet
polymorph
extracellular
product
enhanc
iav
suscept
vitro
show
shape
extracellular
environ
power
mechan
vast
arsen
innat
immun
respons
invad
pathogen
identifi
isg
effector
target
late
stage
iav
life
cycl
establish
highthroughput
imagebas
screen
use
extend
version
recent
publish
isg
librari
compris
cdna
schoggin
et
al
tabl
human
lung
adenocarcinoma
cell
transduc
lentivir
vector
express
individu
isg
figur
hr
cell
challeng
iav
moi
spread
ratio
calcul
number
infect
cell
hr
postinfect
hpi
rel
hpi
isg
figur
screen
perform
twice
use
independ
gener
lentiviru
librari
figur
antibodi
spread
ratio
posit
control
wherea
empti
vector
control
spread
ratio
figur
nineteen
isg
reduc
iav
spread
ratio
greater
two
sd
empti
vector
control
screen
figur
tabl
among
isg
sever
broadli
act
antivir
factor
involv
pattern
recognit
ifn
signal
rigi
inflammatori
cytokin
rant
broadli
act
iavspecif
inhibitor
schneider
et
al
act
earli
iav
entri
replic
wherea
also
known
tetherin
prevent
releas
bud
viru
particl
host
cell
surfac
although
conflict
data
exist
iav
inhibit
tetherin
mangeat
et
al
watanab
et
al
yondola
et
al
potent
inhibit
spread
cell
subsequ
use
posit
control
also
identifi
number
isg
previous
uncharacter
antivir
activ
trail
maff
serin
proteas
inhibitor
member
valid
set
gene
independ
gener
hightit
lentivir
stock
cell
well
normal
human
bronchial
epitheli
cell
nhbe
inhibit
viru
spread
nhbe
cell
confirm
antivir
figur
exclud
fals
posit
due
cytotox
test
cell
prolifer
apoptosi
dna
damag
cell
death
profil
highthroughput
microscopi
htm
figur
found
express
potent
hit
screen
cytotox
rel
empti
vector
control
proteas
inhibitor
use
clinic
treat
virus
eg
hiv
endogen
effector
similar
function
promis
lead
therefor
focus
explor
antivir
action
encod
express
inhibit
spread
variou
clinic
iav
isol
includ
deriv
highli
pathogen
avian
influenza
viru
modifi
remov
polybas
cleavag
site
viral
hemagglutinin
steel
et
al
halo
pandem
isol
swine
origin
figur
multistep
viral
growth
kinet
express
reduc
extracellular
iav
titer
compar
inhibit
tetherin
figur
versatil
serpin
famili
member
implic
mani
physiolog
process
includ
regul
fibrinolysi
review
declerck
gil
howev
sinc
antivir
effector
function
protein
context
intrins
immun
respons
novel
set
determin
role
restrict
iav
infect
first
studi
kinet
gene
express
well
protein
product
secret
compar
cell
relev
vitro
model
nhbederiv
differenti
human
ciliat
airway
epithelium
cultur
haec
mimic
morpholog
physiolog
airway
epithelium
vivo
cell
mrna
slightli
upregul
upon
stimul
follow
infect
iav
figur
due
nonrespons
cell
sinc
isg
highli
upregul
figur
known
trigger
express
via
canon
pathway
et
al
inde
treatment
cell
strongli
induc
express
modest
effect
mrna
level
figur
stimul
gene
express
led
increas
intracellular
extracellular
level
figur
consist
effici
secret
total
level
supernat
higher
respect
cell
lysat
hr
figur
observ
apic
secret
haec
either
iav
infect
figur
treatment
figur
note
even
mocktreat
cell
haec
constantli
produc
secret
basal
level
accumul
time
figur
howev
upregul
certain
stimuli
includ
viru
infect
test
possibl
iav
inhibit
extracellular
ad
recombin
activ
supernat
cell
iav
infect
decreas
iav
spread
dosedepend
manner
figur
convers
use
polyclon
antibodi
target
f
neutral
abil
inhibit
proteas
komissarov
et
al
strikingli
found
addit
antibodi
cell
infect
significantli
enhanc
iav
spread
compar
igg
control
figur
thu
far
extracellular
environ
experi
defin
compon
growth
medium
protein
secret
cultur
cell
endogen
overexpress
test
potenc
natur
set
examin
iav
growth
kinet
haec
presenc
absenc
strikingli
addit
rpai
apic
side
haec
significantli
reduc
iav
growth
compar
carrier
control
lower
infect
hpi
figur
contrast
addit
antibodi
dramat
enhanc
iav
growth
earli
hpi
continu
throughout
cours
infect
cell
haec
human
parainfluenzaviru
unaffect
either
treatment
show
effect
select
iav
due
cytotox
figur
experi
probe
stage
viral
life
cycl
affect
show
effect
earli
stage
replic
egress
figur
howev
reduct
progeni
particl
infect
figur
togeth
extracellular
presenc
figur
welldescrib
function
proteas
inhibitor
declerck
gil
led
us
investig
activ
mechanist
basi
iav
inhibit
infect
iav
progeni
particl
requir
matur
cleavag
viral
hemagglutinin
catalyz
host
proteas
lazarowitz
choppin
skehel
waterfield
test
whether
known
hacleav
proteas
might
direct
target
inhibit
inhibit
proteas
function
form
coval
sdsstabl
bond
target
proteas
detect
gel
shift
assay
urokinas
plasminogen
activ
upa
major
target
form
complex
kda
presenc
inhibitor
triplaxtinin
figur
tpcktrypsin
anoth
establish
target
prototyp
chymotrypsinlik
serin
proteas
olson
et
al
allow
multipl
round
iav
infect
cell
lack
endogen
hacleav
proteas
trypsin
typic
ad
low
concentr
tissu
cultur
medium
readili
detect
complex
form
vitro
degrad
product
absent
triplaxtinin
ad
figur
furthermor
identifi
human
tryptas
human
airway
trypsin
hat
target
figur
contrast
unabl
detect
complex
furin
although
interact
previous
report
figur
bernot
et
al
use
host
proteas
matur
uniqu
iav
paramyxovirus
also
use
airway
proteas
cleav
surfac
fusion
f
glycoprotein
sendai
viru
sev
util
extracellular
airway
proteas
iav
tashiro
et
al
contrast
f
cleav
intracellularli
ubiquit
endoproteas
furin
use
spread
assay
trypsin
proteas
found
inhibit
wherea
iav
sev
exhibit
reduc
spread
figur
encod
catalyt
inact
due
singl
point
mutat
reactiv
center
loop
serv
lossoffunct
neg
control
lawrenc
et
al
data
clearli
demonstr
target
trypsinlik
airway
proteas
need
extracellular
viru
matur
next
examin
effici
ha
cleavag
presenc
trypsin
found
complet
block
trypsinmedi
cleavag
figur
furthermor
express
wildtyp
inact
mutant
reduc
specif
infect
iav
puerto
grown
presenc
trypsin
figur
found
similar
result
extracellular
airway
proteas
transmembran
proteas
serin
hat
known
hacleav
proteas
hatesu
et
al
figur
treatment
addit
trypsin
prior
viru
titrat
restor
specif
infect
level
viru
grown
presenc
either
proteas
suggest
defect
specif
infect
inde
caus
uncleav
ha
figur
next
investig
cleavag
effici
ha
differ
clade
apuerto
wildtyp
highli
pathogen
figur
uncleav
baselin
readili
cleav
either
exogen
trypsin
overexpress
figur
slight
differ
size
trypsin
ha
previous
shown
caus
alter
glycosyl
pattern
cell
bertram
et
al
found
wildtyp
mutant
inhibit
cleavag
ha
subtyp
contrast
cleavag
mediat
endogen
intracellular
proteas
furin
impair
figur
result
line
data
gel
shift
assay
figur
experi
furindepend
figur
suggest
furin
inde
inhibit
final
examin
cleavag
state
ha
haec
cultur
produc
secret
intrins
airway
proteas
apic
side
fact
previous
enabl
identif
sever
proteas
cleav
ha
et
al
addit
haec
iav
infect
dramat
reduc
ha
cleavag
wherea
addit
increas
cleavag
figur
find
agreement
previou
result
demonstr
viru
growth
kinet
haec
figur
taken
togeth
data
show
inhibit
iav
spread
reduc
extracellular
cleavag
matur
progeni
particl
mechan
oper
physiolog
relev
model
airway
epithelium
examin
role
iav
infect
vivo
infect
control
mice
intranas
iav
puerto
vesicular
stomat
viru
vsv
control
transcript
upregul
mous
lung
upon
iav
infect
figur
also
detect
increas
level
murin
mous
lung
cours
iav
infect
increas
dpi
compar
pbstreat
figur
mrna
protein
undetect
lung
homogen
iavinfect
mice
exhibit
signific
weight
loss
succumb
infect
averag
day
earlier
parent
mice
figur
differ
observ
mice
infect
vsv
control
figur
despit
modest
differ
surviv
lung
iav
titer
late
time
infect
significantli
elev
figur
correl
level
keller
et
al
use
mice
studi
effect
influenza
viru
infect
thrombosi
found
impact
iav
infect
measur
amount
viral
rna
day
dpi
howev
given
role
block
viral
matur
level
infecti
viru
particl
figur
relev
measur
mice
exhibit
intermedi
phenotyp
respect
weight
loss
surviv
murin
lung
level
indic
codomin
effect
iav
infect
figur
lung
increas
size
day
postiav
infect
enhanc
necrosi
compar
lung
control
figur
bleed
alveoli
slightli
enhanc
infect
lung
dpi
might
expect
given
role
fibrinolysi
figur
cytokin
express
elev
iavinfect
lung
compar
control
lung
indic
increas
inflamm
figur
contrast
cytokin
level
uninfect
lung
lung
mice
intranas
challeng
poli
c
compar
genotyp
figur
thu
increas
weight
loss
death
observ
mice
iav
infect
simpli
attribut
global
upregul
cytokin
wherea
cytokin
level
began
decreas
iavinfect
lung
dpi
suggest
subsid
infect
stagnat
lung
indic
ongo
infect
mice
correl
presenc
higher
iav
titer
mice
late
time
point
confirm
vivo
phenotyp
gener
murin
tracheal
epitheli
cultur
mtec
trachea
wildtyp
mice
similar
haec
challeng
found
significantli
increas
vrna
infecti
viru
cultur
later
time
infect
figur
result
strengthen
physiolog
relev
regul
iav
spread
compon
host
barrier
restrict
iav
infect
vivo
sever
singl
nucleotid
polymorph
snp
often
link
bleed
disord
describ
fay
et
al
zhang
et
al
snp
locat
signal
peptid
sequenc
result
substitut
alanin
threonin
partial
intracellular
retent
fact
heterozyg
carrier
reduc
serum
tendenc
hemorrhag
zhang
et
al
character
iav
suscept
three
human
fibroblast
line
least
one
allel
two
heterozyg
design
ta
figur
one
homozyg
aa
compar
three
control
line
encod
wildtyp
tt
found
iav
spread
significantli
enhanc
three
fibroblast
line
compar
control
figur
due
enhanc
replic
least
ta
aa
number
infect
cell
one
round
replic
similar
control
figur
multicycl
growth
experi
observ
variat
control
line
common
donor
genet
heterogen
howev
found
fibroblast
line
produc
significantli
infecti
viru
compar
three
control
figur
determin
whether
phenotyp
select
iav
challeng
fibroblast
inde
two
three
fibroblast
line
ta
aa
support
increas
spread
replic
determin
htm
multicycl
growth
assay
figur
howev
ta
exhibit
enhanc
spread
replic
compar
control
previous
observ
enhanc
iav
replic
figur
suggest
cell
line
may
properti
unrel
promot
viru
replic
spread
extracellular
level
fibroblast
cultur
control
consist
previou
report
figur
zhang
et
al
next
attempt
rescu
iav
spread
inhibit
ad
cultur
medium
aa
ta
aa
cell
iav
infect
dramat
reduc
viru
spread
ta
aa
cell
level
tt
control
cell
dosedepend
manner
contrast
control
fibroblast
support
enhanc
spread
harbor
reduc
extracellular
level
could
rescu
level
tt
control
figur
result
show
natur
extracellular
defici
correl
increas
iav
spread
identifi
serin
proteas
inhibitor
isg
restrict
iav
spread
character
previous
undescrib
antivir
function
kda
glycoprotein
main
physiolog
inhibitor
urokinasetissu
plasminogen
activ
upatpa
major
regul
fibrinolyt
system
upatpa
convert
zymogen
plasminogen
plasmin
trigger
proteolyt
cascad
dissolv
blood
clot
review
declerck
gil
present
plasma
platelet
extracellular
matrix
secret
endotheli
smooth
muscl
immun
cell
differ
tissu
includ
airway
upatpa
inhibit
multipl
serin
proteas
chymotrypsin
type
vari
effici
irv
et
al
find
three
new
proteas
target
human
tryptas
tryptas
clara
club
cell
secretori
protein
hat
involv
extracellular
iav
glycoprotein
cleavag
find
suggest
role
antivir
factor
target
extracellular
matur
iav
particl
iav
matur
involv
cleavag
surfac
glycoprotein
ha
protein
remain
link
via
disulfid
bond
skehel
waterfield
form
hing
prerequisit
viral
envelop
fusion
entri
klenk
et
al
lazarowitz
choppin
iav
encod
proteas
ha
cleavag
depend
presenc
host
proteas
site
iav
replic
furin
member
subtilisinlik
famili
serineproteas
known
cleav
ha
intracellularli
horimoto
et
al
et
al
could
find
evid
inhibit
furin
human
tryptas
hat
mosaic
serin
proteas
largeform
mspl
matrix
metalloproteinas
plasmin
known
extracellular
hacleav
proteas
lazarowitz
et
al
review
bertram
et
al
member
chymotrypsinlik
serin
proteas
famili
target
famili
provid
direct
proof
effici
inhibit
trypsin
cleavag
ha
hypothes
might
inhibit
member
proteas
famili
well
access
glycoprotein
cleavag
major
determin
iav
pathogen
bosch
et
al
whether
effici
ha
subtyp
cleav
given
proteas
determin
cleavag
site
sequenc
highli
pathogen
avian
contain
multibas
cleavag
site
make
access
ubiquiti
express
intracellular
proteas
like
furin
bosch
et
al
henc
viral
particl
subtyp
immedi
matur
infecti
upon
bud
less
pathogen
iav
contrast
contain
singl
arginin
residu
cleavag
site
make
depend
cleavag
extracellular
airway
proteas
variat
amino
acid
sequenc
surround
arginin
alter
cleavag
effici
galloway
et
al
recent
studi
mice
reveal
direct
influenc
pathogen
iav
strain
reli
proteas
hatesu
et
al
sakai
et
al
tarnow
et
al
absenc
iav
origin
unabl
spread
trachea
lung
make
mice
highli
resist
case
highli
pathogen
viru
sakai
et
al
thu
sensit
inhibit
inhibit
proteas
inhibitor
depend
natur
cleav
proteas
well
cleavag
effici
specif
ha
subtyp
proteas
figur
regard
interest
determin
whether
proteas
inhibitor
differenti
impact
pathogen
differ
iav
subtyp
vivo
surprisingli
ha
cleavag
propos
target
antivir
therapi
synthet
inhibitor
morpholino
peptid
mimet
proteas
inhibitor
use
target
singl
proteas
et
al
leupeptin
actinomyc
origin
synthet
drug
camostat
aprotinin
bovin
lung
broader
antiproteas
activ
beppu
et
al
lee
et
al
tashiro
et
al
zhirnov
et
al
recombin
mucu
proteas
inhibitor
mpi
previous
known
airway
proteas
inhibitor
human
origin
antiiav
activ
beppu
et
al
efficaci
appli
molecul
restrict
iav
demonstr
vitro
vivo
valid
ha
cleavag
inhibit
attract
antivir
strategi
data
show
employ
mechan
first
known
host
proteas
inhibitor
function
protect
host
natur
iav
infect
somewhat
unconvent
isg
constitut
express
upregul
ifn
cytokin
like
medcalf
signific
hacleav
proteas
often
upregul
iav
infect
skew
proteaseproteas
inhibitor
balanc
favor
viru
kido
et
al
thu
may
tip
balanc
back
toward
host
regul
might
particularli
relev
iav
infect
iav
neuraminidas
activ
latent
carlson
et
al
sourc
airway
infect
includ
secret
macrophag
epitheli
cell
interest
upregul
gene
express
infect
dramat
isg
possibl
reflect
critic
role
local
system
physiolog
process
massiv
overproduct
could
deleteri
blood
clot
cancer
metastasi
cell
adhes
migrat
review
declerck
gil
serpin
latent
form
vivo
provid
regulatori
mechan
spatial
tempor
berkenpa
et
al
respiratori
tract
major
portal
viru
entri
bodi
protect
multilay
antivir
fenc
mucu
act
physic
extracellular
barrier
mucin
surfact
protein
mucu
trap
aggreg
viru
particl
outsid
cell
act
decoy
receptor
inhibit
earli
step
viral
replic
cycl
hartshorn
et
al
read
et
al
mucin
present
airway
constitut
level
upregul
inflamm
turner
jone
add
addit
compon
extracellular
barrier
first
extracellular
directli
antivir
isg
promiscu
suggest
may
also
play
import
role
host
defens
respiratori
virus
reli
step
life
cycl
mani
viru
famili
requir
matur
cleavag
viral
surfac
glycoprotein
gener
realiz
serin
proteas
use
virusencod
proteas
picornavirus
retrovirus
brodi
et
al
lee
et
al
other
paramyxovirus
orthomyxovirus
coronavirus
filovirus
arenavirus
reli
host
proteas
glowacka
et
al
lenz
et
al
skehel
waterfield
steinhauer
plemper
volchkov
et
al
potenti
sensit
inhibit
activ
proteas
host
pharmacolog
proteas
inhibitor
inde
show
singl
inhibitor
significantli
inhibit
spread
iav
sev
explor
inhibitor
troika
may
open
new
avenu
antivir
intervent
deepen
understand
viru
matur
pathogen
conclus
identifi
host
factor
inhibit
iav
spread
show
mechanist
act
block
matur
progeni
iav
particl
thu
reduc
particl
infect
natur
occur
human
genet
variat
impact
abil
iav
spread
cell
cell
thu
identifi
candid
human
gene
may
influenc
suscept
iav
outcom
infect
regard
immedi
interest
determin
whether
defici
might
link
sever
human
iav
infect
final
work
suggest
local
administr
respiratori
tract
might
provid
new
therapeut
approach
treat
iav
respiratori
virus
requir
extracellular
proteasedriven
matur
use
gateway
technolog
transfer
previous
publish
librari
isg
schoggin
et
al
orfexpress
entri
clone
new
lentivir
express
vector
pscrpsi
coexpress
tagrfp
transduct
control
puromycin
resist
cell
plate
first
transduc
challeng
iav
moi
due
vari
transduct
effici
lentivir
stock
percentag
nontransduc
cell
variabl
iav
product
nontransduc
cell
mask
potenti
inhibitori
effect
isg
elimin
ad
puromycin
hr
prior
iav
infect
lentivir
transduct
perform
duplic
plate
isg
one
sampl
fix
one
round
replic
hpi
defin
number
initi
produc
cell
sever
round
replic
hpi
spread
ratio
calcul
divid
iavinfect
cell
hpi
hpi
individu
isg
empti
vectortransduc
cell
figur
yield
result
stabl
wide
rang
transduct
effici
figur
infect
cell
detect
stain
iav
nucleoprotein
np
htm
figur
mice
hous
aaalacaccredit
facil
accord
guid
care
use
laboratori
anim
procedur
outlin
studi
approv
rockefel
univers
institut
anim
care
use
committe
wildtyp
breeder
pair
purchas
jackson
laboratori
coloni
establish
inhous
six
tenweekold
mice
sex
use
iav
challeng
mice
use
vsv
experi
inform
consent
obtain
human
subject
accord
local
regul
sampl
subsequ
transfer
experiment
test
respect
ethic
approv
inserm
franc
rockefel
univers
usa
protocol
involv
use
human
tissu
review
exempt
rockefel
univers
institut
review
board
extend
experiment
proceduresvirus
cell
plasmidsegggrown
influenza
virus
apuerto
halo
pandem
obtain
peter
pales
apuerto
report
viru
adolfo
garciasastr
human
parainfluenza
viru
gfp
gift
peter
collin
niaid
nih
receiv
sendai
virusgfp
dominiqu
garcin
univers
geneva
iav
grown
mdck
cell
vesicular
stomat
viru
strain
indiana
grown
titrat
bhk
cell
adenocarcinom
human
alveolar
basal
epitheli
cell
rhesu
macaqu
kidney
cell
purchas
atcc
normal
human
bronchialtrach
epitheli
cell
nhbe
lonzahuman
airway
tracheobronchi
epitheli
cell
isol
airway
specimen
patient
normal
lung
provid
lonza
inc
walkersvil
md
primari
cell
deriv
singl
patient
sourc
expand
plastic
gener
passag
cell
subsequ
plate
cellswel
rattail
collagen
type
permeabl
transwel
membran
support
mm
corn
inc
hae
cultur
grown
bali
medium
supplement
induc
lonza
inc
media
chang
provis
airliquid
interfac
approxim
week
form
differenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epitheliumfor
infect
hae
rins
pb
transient
remov
apic
secret
suppli
fresh
basolater
medium
prior
inocul
use
pfu
respect
per
cultur
viru
dilut
pb
supplement
either
ng
buffer
mm
mm
nacl
mm
edta
ph
ng
abcam
ng
rabbit
igg
control
per
cultur
inoculum
appli
apic
surfac
hae
hr
follow
incub
viral
inocula
remov
cultur
wash
time
pb
buffer
igg
replenish
volum
per
cultur
cultur
incub
durat
experi
progeni
viru
harvest
indic
time
perform
apic
wash
pb
min
wash
rpai
buffer
igg
replenish
wash
harvest
store
prior
analysi
viral
titer
apic
wash
determin
plaqu
assay
mdck
cell
assay
cell
primari
human
dermal
fibroblast
obtain
punch
biopsi
human
subject
cohort
variou
infecti
diseas
cell
electropor
plasmid
encod
simian
viru
larg
antigen
creat
fibroblast
maintain
dmem
invitrogen
supplement
gentamycin
fb
primari
cell
longer
presentto
screen
isg
antivir
activ
obtain
sequencevalid
orfexpress
isg
shuttl
clone
genecopoeia
use
gateway
technolog
move
gene
pscrpsi
lentivir
vector
coexpress
rfp
puromycin
resist
gene
clone
ta
life
technolog
entri
clone
dna
use
templat
insert
mutat
use
quikchang
technolog
agil
refer
previous
describ
convey
loss
function
lawrenc
et
al
wildtyp
move
either
pscrpsi
lentiviru
product
life
technolog
transfect
pcaggslic
obtain
david
steinhauer
emori
univers
atlanta
plasmid
encod
hat
obtain
gari
whittak
cornel
univers
ithaca
antibodi
stain
recombin
proteinsfor
highthroughput
microscopi
use
np
mab
millipor
conjug
life
technolog
antiphosphoryl
pierc
sytox
green
dead
cell
stain
life
technolog
secondari
antibodi
block
spread
iav
tissu
cultur
use
mab
kind
gift
adolfo
garciasastr
neutral
cell
supernat
use
rabbit
polyclon
abcam
dilut
rabbit
igg
jackson
immunoresearch
control
visual
ha
western
blot
follow
reagent
obtain
nih
biodefens
emerg
infect
research
resourc
repositori
niaid
nih
polyclon
antiinfluenza
viru
hemagglutinin
ha
apuerto
antiserum
goat
polyclon
antiinfluenza
viru
hemagglutinin
ha
antiserum
goat
polyclon
antiinfluenza
viru
hemagglutinin
ha
antiserum
goat
use
recombin
activ
human
carri
stabil
mutat
abcam
tissu
cultur
ngml
final
concentr
vitro
assay
tpck
trypsin
human
tryptas
sigma
recombin
hat
r
system
recombin
activ
furin
abcam
neb
recombin
activ
urokinas
plasminogen
activ
abcam
use
serial
dilut
start
use
stabl
form
carri
four
amino
acid
chang
prolong
halflif
hr
berkenpa
et
al
target
level
experi
chosen
reflect
physiolog
concentr
ngml
respectivelyhighthroughput
microscopi
screen
host
factor
cell
plate
transduc
lentivir
isg
stock
duplic
plate
infect
iav
pfuwel
moi
puromycin
select
appli
min
prior
iav
challeng
end
experi
suppress
viru
product
untransduc
cell
detect
singl
round
infect
cell
fix
paraformaldehyd
hpi
monitor
viral
spread
duplic
well
fix
hpi
cell
permeabil
triton
pb
stain
npposit
cell
dapi
fish
gelatin
pb
use
block
reagent
wash
step
immunostain
perform
use
biotek
plate
washer
dispens
overlap
imag
per
well
taken
use
imagexpressmicro
system
molecular
devic
imag
stitch
analyz
total
dapi
transduc
rfp
infect
cell
metaxpress
softwar
valu
normal
respect
earli
valu
account
differ
transduct
effici
determin
number
cell
infect
late
stage
one
initi
infect
cell
founder
cell
isg
hit
valid
experi
gener
lentivir
stock
independ
primari
screen
prepar
indic
respect
figur
modifi
htm
protocol
regard
cell
type
viru
time
time
pointsisg
induct
assaysto
determin
mrna
express
protein
secret
kinet
treat
cell
hae
cultur
follow
condit
abcam
abcam
pgml
iav
infect
moi
hae
mrna
level
normal
housekeep
gene
determin
qrtpcr
superscript
iii
first
strand
synthesi
system
life
technolog
sybr
green
assay
roch
describ
previous
primer
sequenc
found
tabl
total
protein
level
cell
supernat
cell
lysat
triton
pb
sonic
min
measur
human
platinum
elisa
bd
bioscienc
level
mous
lung
homogen
measur
total
mous
elisa
kit
abcam
inhibitorsal
inhibitor
use
tissu
cultur
titrat
toxic
sytox
stain
annexinv
stain
prestoblu
assay
subsequ
use
highest
possibl
noncytotox
dose
diphyllin
chemdiv
use
block
iav
entri
ribavirin
replic
inhibit
control
respect
triplaxtinin
axonmedchem
use
inhibitor
vitro
assay
jak
inhibitor
calbiochem
use
ngml
sevgfp
spread
assaysviru
infect
mediaunless
state
otherwis
follow
media
use
viru
infect
cell
dmem
bsa
equitech
fb
penstrep
tpcktrypsin
infect
human
fibroblast
use
dmem
proteasefre
bsa
sigma
fb
penstrep
tpcktrypsin
infect
serumfre
condit
bhk
cell
mem
penstrep
use
without
addit
tpck
indic
use
serumfre
overlay
plaqu
assay
mdck
cell
dmem
deae
glutamax
neaa
tpck
avicel
oxoid
agar
iav
lifecycl
assaysw
transduc
indic
lentivirus
perform
assay
mini
genom
assay
transduc
cell
transfect
format
pcagg
construct
iav
pa
ng
np
empti
pcagg
well
rna
polymeras
iidriven
renilla
luciferas
report
prltk
ng
iavspecif
rna
polymeras
idriven
firefli
luciferas
report
ppoliluc
ng
diphyllin
ribavirin
ad
control
transfect
end
experi
cell
harvest
posttransfect
lyse
assay
use
dual
luciferas
assay
kit
promega
determin
egress
effici
transduc
challeng
iav
moi
hpi
cell
harvest
quantit
intracellular
vrna
supernat
determin
extracellular
vrna
number
infecti
particl
viral
rna
extract
rneasi
kit
qiagen
cell
qiamp
viral
rna
kit
qiagen
supernat
genom
quantif
taqman
rtpcr
use
realtim
readi
rna
viru
master
roch
primer
probe
sequenc
found
tabl
number
infecti
particl
supernat
determin
plaqu
assay
mdck
cell
use
avicel
overlay
crystal
violet
stain
agar
overlay
follow
npimmunostain
ha
cleavag
specif
infect
assaysfor
ha
cleavag
assay
trypsin
rpai
bhk
cell
transfect
plate
serumfre
mem
either
pcagg
encod
posttransfect
mem
replac
fresh
mem
mem
contain
tpck
mem
contain
mix
tpck
rpai
previous
incub
cell
incub
min
float
cell
media
collect
centrifug
remain
adher
cell
harvest
mlwell
enzymefre
pbsbase
dissoci
reagent
scrape
cleavag
assay
presenc
bhk
cell
transfect
respect
ha
plasmid
plasmid
plu
plasmid
posttransfect
trypsin
ad
control
well
min
cell
harvest
scrape
collect
centrifug
lyse
nupag
load
buffer
reduc
agent
ha
cleavag
analyz
western
blot
use
antibodi
specif
respect
hafor
specif
infect
assay
bhk
cell
cotransfect
mem
previous
publish
proteaseencod
plasmid
hat
plasmid
encod
wildtyp
mutant
posttransfect
media
collect
cell
wash
twice
pb
infect
serumfre
mem
moi
incub
cell
wash
overlaid
media
contain
proteas
supernat
collect
plaqu
assay
vrna
vrna
determin
qrtpcr
ffu
focu
form
assay
rescu
specif
infect
duplic
supernat
incub
addit
tpcktrypsin
dilut
medium
min
prior
focu
form
assaymicewildtyp
refer
mice
anesthet
ketaminexylazin
mgkg
iav
viru
dilut
volum
administ
intranas
doserespons
experi
wsn
wt
ko
mice
show
correspond
pfu
optim
reveal
differ
wt
ko
mice
regard
weight
loss
surviv
viral
titer
vsv
strain
indiana
pfu
per
mous
administ
intranasallyclin
sign
assess
visual
inspect
well
daili
weigh
anim
anim
becam
moribund
lost
bodi
weight
compar
day
immedi
euthanizedfor
poli
c
challeng
experi
mice
anesthet
ketaminexylazin
mgkg
poli
c
invivogen
dilut
pb
volum
administ
intranasallyfor
determin
viru
lung
titer
isg
mrna
profil
anim
sacrif
indic
time
point
whole
lung
collect
homogen
pb
debri
spun
rpm
min
supernat
analyz
plaqu
assay
qrtpcr
primer
sequenc
mous
isg
sybr
green
assay
found
tabl
patholog
follow
euthanasia
inhal
chest
open
neutral
buffer
formalin
nbf
inject
trachea
syring
g
needl
lung
expand
normal
situ
size
lung
immers
nbf
later
process
ethanol
xylen
embed
paraffin
section
thick
stain
hematoxylin
eosin
one
longitudin
section
obtain
pair
lung
includ
whole
lung
major
airway
slide
examin
boardcertifi
veterinari
pathologist
bleed
score
semiquantit
absent
minim
mild
moder
mark
primari
mous
tracheal
epitheli
cell
cultureisol
cultur
primari
mous
tracheal
epitheli
cell
cultur
mtec
perform
previous
describ
briefli
trachea
wash
media
open
longitudin
incub
ham
contain
mgml
pronas
hr
isol
enzymat
treatment
seed
onto
pore
size
clear
polyest
membran
corn
coat
collagen
solut
confluenc
media
remov
upper
chamber
establish
airliquid
interfac
ali
fulli
differenti
dayold
postali
cultur
use
experimentsfor
infect
apic
surfac
mtec
cultur
wash
extens
remov
accumul
mucin
inocul
influenza
viru
moi
incub
hr
viru
inoculum
remov
cultur
incub
complet
growth
medium
aliquot
supernat
collect
differ
time
point
viru
titrationrna
isol
mtec
cultur
directli
lyse
cell
transwel
use
qiagen
rneasi
mini
kit
accord
manufactur
instruct
total
rna
reversetranscrib
use
thermoscript
rtpcr
system
kit
invitrogen
cdna
serv
templat
amplif
gene
interest
housekeep
gene
realtim
pcr
use
taqman
gene
express
assay
appli
biosystem
univers
pcr
master
mix
appli
biosystem
abipr
sequenc
detect
system
appli
biosystem
fold
increas
mrna
express
determin
use
method
rel
valu
mock
treat
sampl
normal
gene
express
viru
quantifi
qpcr
matrix
gene
primer
sequenc
found
tabl
altern
viru
titrat
mdck
cell
tissu
cultur
infect
dose
eight
replic
serial
dilut
accord
spearmankarb
method
hhh
ma
contribut
equal
work
md
cmr
design
project
md
wrote
manuscript
md
hhh
ma
klb
sc
aw
cmr
design
experi
md
hhh
ma
rhg
klb
bf
yy
sc
jwx
perform
experiment
work
md
ma
hhh
sjc
aw
analyz
result
sjw
mc
aw
pdb
jlc
contribut
reagent
expertis
